STRONTIUM RANELATE (STRONTIUM RANELATE)
Overview of STRONTIUM RANELATE
Strontium ranelate is bone metabolism modulator; inhibits bone resorption while maintaining bone formation and Antiosteoporotic agent. It is used for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures. Its cemical formula is C12H6N2O8SSr2.
Indication of STRONTIUM RANELATE
STRONTIUM RANELATE is primarily indicated in conditions like Osteoporosis in postmenopausal women.
Contraindication of STRONTIUM RANELATE
STRONTIUM RANELATE is contraindicated in conditions like Hypersensitivity to any component of product.
Side Effects of STRONTIUM RANELATE
STRONTIUM RANELATE produces potentially life-threatening effects which include Seizures, Hypersensitivity, blood clots. which are responsible for the discontinuation of STRONTIUM RANELATE therapy.,The symptomatic adverse reactions produced by STRONTIUM RANELATE are more or less tolerable and if they become severe, they can be treated symptomatically, these include Loose stools, Headache, Vomiting, Diarrhea, Abdominal pain, Hair loss, Oral ulceration, Muscle cramps, Eczema.
Precautions of STRONTIUM RANELATE
Not recommended for use in patients with CrCl <30 ml/min. Patients at increased risk of venous thromboembolism.